This is the Global Health Checkup, five of the week’s most important stories on outbreaks, medicine, science, and survival from around the world. This week: a breakthrough on the price of a new HIV ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...

ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. Current ...

Uganda is set to introduce a new long-acting HIV prevention drug, Lenacapavir, in 2026 under a United States-funded ...